Blog

Blog2023-08-08T17:17:12-04:00

Cognitive Development in Children Exposed to Levetiracetam (Keppra)

An increasing number of reproductive age women now take newer anticonvulsants for the treatment of mood and anxiety disorders; however, information regarding the reproductive safety of these medications is limited.  A recent study has evaluated the cognitive and language development of children born to women with epilepsy exposed in utero to levetiracetam (LEV, Keppra) or sodium valproate (VPA, Depakote), as compared to control children born to women without epilepsy not taking medication during pregnancy.

January 14th, 2014|

New Baby 101: Practical Intervention Strategy Reduces the Risk of Postpartum Depression

An intervention teaching new parents about normal infant sleeping and crying patterns and providing them with techniques for infant settling improves mothers' depression scores. There were no differences in scores on the Edinburgh Postnatal Depression Scale (EPDS) at 4 months, but at 6 months, caregivers in the intervention group were almost half as likely to score higher than 9 on the EPDS, with 7.9% scoring higher than 9 in the intervention group vs. 12.9% in the control cohort (adjusted odds ratio [AOR], 0.57).

January 13th, 2014|

Earlier Age of Surgical Menopause Associated with More Significant Cognitive Decline

Previous studies have shown that the abrupt hormonal changes that occur after a surgical menopause (i.e., removal of the ovaries) negatively affect cognition in women.  According to a recent study, "Women who were younger at the time of surgical menopause have a more rapid rate (steeper slope) of cognitive decline than women who were older at the time of surgery or than women undergoing natural menopause."  Earlier age at menopause was also associated with increased Alzheimer’s disease neuropathology, in particular neuritic plaques.

December 23rd, 2013|
Go to Top